MT027 cells suspension Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

Suzhou Maximum Bio-tech Co., Ltd.1

Indications

Pleural Malignant Mesothelioma1
Pleura Carcinoma1
Malignant Pleural Effusion1
Pleural Metastases1
Pleural Mesothelioma1

Other1 trial

A Study of MT027 in Patients with Pleural Malignant Tumors

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.